Gene · 6009
Papers4,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer's disease. | Alzheimers Res Ther | 2023 | 37452431 | PubTator, text mining | PubMed |
| The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review. | Int J Mol Sci | 2023 | 37446128 | PubTator, text mining | PubMed |
| The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics. | Int J Mol Sci | 2023 | 37445831 | PubTator, text mining | PubMed |
| The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment. | Cancers (Basel) | 2023 | 37444578 | PubTator, text mining | PubMed |
| Investigation of Potential Drug Targets for Cholesterol Regulation to Treat Alzheimer's Disease. | Int J Environ Res Public Health | 2023 | 37444065 | PubTator, text mining | PubMed |
| Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing. | Cells | 2023 | 37443788 | PubTator, text mining | PubMed |
| Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. | MedComm (2020) | 2023 | 37441462 | PubTator, text mining | PubMed |
| The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition. | Cancer Res Commun | 2023 | 37441266 | PubTator, text mining | PubMed |
| Prediction of Translational Regulation by Network Interaction in Synaptic Plasticity Induced with Centella asiatica. | ScientificWorldJournal | 2023 | 37440991 | PubTator, text mining | PubMed |
| The covert symphony: cellular and molecular accomplices in breast cancer metastasis. | Front Cell Dev Biol | 2023 | 37440925 | PubTator, text mining | PubMed |
| Prognostic value of RGS1 and mTOR Immunohistochemical expression in Egyptian multiple myeloma patients; A single center study. | PLoS One | 2023 | 37437037 | PubTator, text mining | PubMed |
| Inhibition of phosphodiesterase 4D suppresses mTORC1 signaling and pancreatic cancer growth. | JCI Insight | 2023 | 37427586 | PubTator, text mining | PubMed |
| Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma. | Nat Commun | 2023 | 37414763 | PubTator, text mining | PubMed |
| Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer. | Mol Cancer Res | 2023 | 37409967 | PubTator, text mining | PubMed |
| Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson-Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies. | Cells | 2023 | 37408186 | PubTator, text mining | PubMed |
| Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy. | Front Oncol | 2023 | 37397394 | PubTator, text mining | PubMed |
| YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer. | Can Respir J | 2023 | 37388902 | PubTator, text mining | PubMed |
| Transcriptomic Context of RUNX3 Expression in Monocytes: A Cross-Sectional Analysis. | Biomedicines | 2023 | 37371794 | PubTator, text mining | PubMed |
| The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds. | Cells | 2023 | 37371141 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model based on autophagy-related genes for hepatocellular carcinoma in the Asian population. | BMC Genomics | 2023 | 37370041 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6009/papers?page=16